Tarragon or Dragon's-wort (Artemisia dracunculus L.) is widely used as spice and in traditional medicine in various regions of the world. Inhibitory effects of the n-hexane, dichloromethane, ethanol and methanol extracts of the leaves of tarragon on the human carbonic anhydrase (hCA) I and II enzymes were investigated. Dichloromethane extract exhibited the strongest activity with lowest IC50 value (0.020 and 0.031 μg/mL, respectively). The chromatographic studies on the dichloromethane extract of tarragon allowed the isolation of six known strong inhibitors of hCA isozymes as trans-anethole, stigmasterol, herniarin, (2E,4E)-N-isobutylundeca-2,4-dien-8,10-diynamide, (2E,4E)-1-(piperidin-1-yl)undeca-2,4-diene-8,10-diyn-1-one and 1-(4'-methoxyphenyl)-1,2,3-trihydroxypropane. The compound, 1-(4'-methoxyphenyl)-1,2,3-trihydroxypropane was isolated from tarragon for the first time in this study. Among the tested compounds, 1-(4'-methoxyphenyl)-1,2,3-trihydroxypropane showed the highest inhibitiory impact on both hCA isozymes. Also its IC50 values were found lower than positive control, acetazolamide.
Introduction
Tarragon or dragon's-wort (Artemisia dracunculus L.), known as "tarhun" or "tarhon" in Anatolia is an edible perennial plant of Asteraceae family. It is a small shrubby and its aromatic leaves is used as spice in salads and vinegars [1, 2] . Besides its tarragon and dragon's-wort common names, it is also named as "estragon, dragon sage-wort, false tarragon and dragon wormwood" [3, 4] . Tarragon is distributed through the temperature regions of Asia, eastern and central Europe and western North America. This species is cultivated in the various region of the world such as southern Europe, Russia, Turkey as well as United
Materials and Methods

Plant and Chemical Materials
Above-ground parts of A. dracunculus L. was purchased from Tiryaki Baharat (Nurs Lokman Hekim) (Erzurum, Turkey) in April 2015. The pure organic solvents were purchased from Tekkim, Fluka and Sigma. Thin layer chromatography (TLC) were applied on silica gel 60F-254 and silica gel 60. The stains on TLC were displayed by UV365, UV254, spraying (1% vanillin-H2SO4) and heating (105 ºC). Column chromatography (CC) was applied by silica gel (200-400 and 70-230). The FT-IR (4000 and 400 cm -1 ) spectra were registered by Nicolet iS10 FT-IR, NMR ( 1 H and 13 C) spectra of isolated substances were registered by Bruker 400 ( 1 H: 400 MHz; 13 C: 100 MHz) spectrometer. CDCl3 was used as solvent, and tetramethylsilane (TMS) was used as an interior standard for the NMR assays. δ (ppm) relative to an interior standard, J (Hz).
Extraction and Isolation Procedures
In order to determine the extracts exhibiting the strongest enzyme inhibitory effect of the A. dracunculus, the powdered above-ground parts of plant (50 g each ones) were individually extracted with n-hexane, dichloromethane, ethanol and methanol (500 mL, 24 h) at room temperature for five times. The extracts were concentrated at low temperature and pressure by a rotary evaporator. The amounts of nhexane, dichloromethane, ethanol and methanol extracts were 4.0, 5.2, 9.6 and 10.0 respectively as g.
Inhibition effects of the extracts were determined on the isozymes (hCA I and hCA II) ( Table 1) . When the results are examined, the IC50 values of the extracts were very close to each other on the hCA isozymes. However, the dichloromethane extract was preferred to purify the active compound and/or compounds due to its the lowest IC50 values. Hence, the dichloromethane extract was subjected to column and thin layer chromatography to isolate bioactive component and/or components from A. dracunculus L. For this purpose, powdered samples of A. dracunculus L. (1.0 kg) were extracted with dichloromethane (5 x 2 L) at room temperature. The extract was concentrated at low temperature and pressure by a rotary evaporator and weighed (52 g). It was exposed to silica gel CC (360 g, 70-230) eluting with CH2Cl2:EtOAc (7:3, v/v) and partitioned into five fractions (Fr.1-Fr.5). Fraction 1 was again subjected to CC on a silica gel column (70 g, 70-230 mesh) using n-hexane:Et2O (9:1, v/v) to obtained compound 1 (7 mg). Likewise, the Fr.2 was repeatedly subjected to CC on a silica gel column by EtOAc:n-hexane (3:7, v/v) to obtained compounds 2 (54 mg), 3 (970 mg), 4 (18 mg) and 5 (419 mg). Compound 6 (15 mg) was isolated over silica gel column chromatography (100 g, 70-230 mesh) from Fr.5 eluting with CHCl3:acetone (9:1, v/v). The spectroscopic data of the isolated compounds are given in below. 
Purification of hCA I and II Isozymes by Affinity Chromatography
Erythrocytes were isolated from fresh human blood got from the Ataturk University Blood Centre. The samples were centrifuged (15 min, 1500 rpm) and the buffy coat and plasma were staved. The red blood cells were purified, cleaned (NaCl, 0.9%) and hemolyzed (ice-cold water, 1.5 v). The intact cells and ghost were staved using centrifuge (20.000 rpm, 30 min). The hemolysate pH was regulated as 8.7 (Tris) [31] . The hemolysate was carried out to the made-up sepharose 4B-tyrosine-sulfanylamide affinity column equalized by 25mM Tris-HCl / 0.1M Na2SO4 (pH 8.7). The affinity gel was cleaned (25 mM Tris-HCl / 22 mM Na2SO4, pH 8.7). The hCA I and II were eluted by 1M NaCl / 25 mM Na2HPO4 (pH 6.3) and 0.1M CH3COONa / 0.5M NaClO4 (pH 5.6), respectively ( Table 2 ). All of processes were applied at temp. 4 ºC [31] . 
Activity of human CA I and II Isozymes
CA isozymes activities were analysed by the change at 348 nm absorbance from 4-nitrophenylacetate to 4-nitrophenylate ion by spectrophotometer (Shimadzu) according to the procedure previously identified (3 min, 25ºC) [32] . A reference measuring was determined at the similar conditions without enzyme solvents. The inhibition activities of A. dracunculus pure substances were investigated. All substances were assayed three times at every concentration. Inhibitor concentrations were applied at different rates. Acetazolamide was used as the reference molecule (Fig. 1) . The activity of control cuvette without inhibitor was taken as 100%. hCA activity was assayed with method of Verpoorte [32] . This method was applied to hCA I and II isozymes with minor modifications. NPA (3 mM) was used as a substrate.
Results and Discussion
Chemical Composition of A. dracunculus
Silica gel CC and TLC studies on the dichloromethane extract, which showed the strongest inhibitory effects on hCA I and II isozymes were allowed the isolation of six known compounds, two phenylpropanoids (1 and 6), one steroid (2), one coumarin (3) Previous reports demonstrated that alkylamides such as pellitorine, neopellitorine A, neopellitorine B, undeca-2E,4E-dien-8,10-dynoic acid isobutylamide (4) and undeca-2E,4E-dien-8,10-dynoic acid piperidylamide (5) are the characteristic metabolites of A. dracunculus, besides herniarin (3), which is the characteristic and major metabolite. [1, 5, 14, 16] . As shown in Figure 1 , in the current study, two alkylamides, undeca-2E,4E-dien-8,10-dynoic acid isobutylamide (4) and undeca-2E,4E-dien-8,10-dynoic acid piperidylamide (5) were isolated. Whereas various phenylpropanoids were reported from the A. dracunculus [1, 5, 15 ], 1-(4'-methoxyphenyl)-1,2,3-trihydroxypropane (6) was characterized from the A. dracunculus for the first time in this study and previously the compound 6 was reported from Illicium verum fruits [33] .
hCA Inhibitory effects of the A. dracunculus Compounds
A. dracunculus is an edible, medicinal and aromatic plant species and it has various beneficial medical properties. Therefore, it has been used in the treatment of various diseases in traditional medicine in the different regions of the world since centuries [1, 5] . A. dracunculus extract and some pure metabolites have also various in vivo and in vitro pharmacological activities such as antibacterial, antimicrobial, antiplatelet, antifungal, anti-inflammatory, antidiabetic, hepatoprotective, gastroprotective and anticonvulsant [1, 4, 20, [34] [35] [36] [37] [38] . Many studies have revealed the therapeutic potentials of A. dracunculus [22, 39, 40] . However, in the literature, there was no study related to the carbonic anhydrase inhibition of A. dracunculus. For this reason, this study was aimed to attract the interest on A. dracunculus L. introducing new biological properties of its extracts and pure metabolites.
Hence, enzyme inhibitor potentials of methanol, ethanol, dichloromethane and n-hexane extracts of A. dracunculus L. and all isolating compounds were investigated on human CA I and II isozymes by comparing of their IC50 values for the first time in the current research. The present results demonstrated that the pure metabolites and extracts of A. dracunculus L. were exhibited various inhibitions on the human CA I and II isozymes ( Table 1) . IC50 values for the extracts tested were given as μg/mL. When the IC50 values of the extracts were compared, they exhibited the approximate value enzyme inhibitory activities ( Table 1 ). The most effective extract was found to be dichloromethane extract for both hCA I and hCA II with the lowest IC50 values, 0.020 μg/mL and 0.031 μg/mL on hCA I and II isozymes, respectively. These results suggested that dichloromethane extract as well as other extracts of A. dracunculus has the hCA enzymes inhibitor potentials. Hence, dichloromethane extract, the most effective extract on the hCA isozymes was subjected to chromatographic studies to isolate active compounds. trans-Anethole (1), stigmasterol (2), herniarin (3), (2E,4E)-N-isobutylundeca-2,4-dien-8,10-diynamide (4) (2E,4E)-1-(piperidin-1-yl)undeca-2,4-diene-8,10-diyn-1-one (5) and 1-(4'-methoxyphenyl)-1,2,3-trihydroxypropane (6) were isolated from dichloromethane extract of A. dracunculus and these compounds tested for enzyme inhibitory activities on the hCA I and II isozymes ( Table 3) . As shown in Table 3 , the pure compounds 1-6 showed various enzyme inhibitory activities with 0.17-486.2 μM and 0.16-123.4 μM of the IC50 values on hCA I and II isozymes, respectively. Among the pure A. dracunculus metabolites, the compound 6, 1-(4'-methoxyphenyl)-1,2,3-trihydroxypropane showed the highest inhibitory effect on the both CA isozymes and the IC50 values of the compound on hCA I and II isozymes were lower than positive control acetazolamide. Furthermore, all A. dracunculus compounds were found to be more effective on the hCA-I isozymes (Table 3) . Whereas, trans-anethole (1), is the major component of A. dracunculus volatiles was determined as least effective compound. Carbonic anhydrase enzyme reversibly catalyzes CO2 and H2O into protons and bicarbonate ions. This enzyme plays an important role in the regulation of fluid balance and pH in different section of living organisms. The transfering of the bicarbonate ions and protons generated in the eyes and kidneys influence the water content of cells. When there is a building up of fluid to maintain the shape of eyes, this fluid can damage the eye, called as glaucoma on the optic nerve in the eye by applying a pressure. In recent years, inhibitors of carbonic anhydrase enzyme in particular hCA II isozymes are used as drug in the treatment of glaucoma [26, 28, [41] [42] [43] . Inhibition of hCA in the patients reduces the fluid pressure and change the fluid balance in the eyes. Besides, some recent reports indicated that treatment of some disorders such as ovarian, breast, colon and kidney cancers, epilepsy and edema are accelerated the process by hCA enzyme inhibitors [26, 28, [44] [45] [46] . Acetazolamide, a diuretic agent is most commonly used in the treatment of glaucoma. Unfortunately, long term use of this drug can affect the similar enzymes in the different tissues and cause side effects such as liver and kidney damage. Thus, we focused on candidate molecules of A. dracunculus herb that could be used in the treatment of glaucoma. According to the results obtained in this study, the compounds isolated from tarragon may be proposed as agent in the treatment of glaucoma. These results concluded that the A. dracunculus molecules except for trans-anethole (1) in particular compound 6 are the potential natural candidate molecules for the treatment of glaucoma.
A carbonic anhydrase enzyme catalyzes transformation of CO2 to bicarbonate ion and proton. There is a zinc ion (Zn 2+ ), which is necessary for catalysis in the active site of most carbonic anhydrase. The several pathological processes containing transformation of CO2 to bicarbonate ion, is involved with carbonic anhydrase reaction. For the remediation of those pathological processes, carbonic anhydrase reactions are inhibited by therapeutical agents. Sulphonamides, sulphamates and sulphamides are compounds known as carbonic anhydrase inhibitors. These compounds bind to the zinc ion of in the active area of carbonic anhydrase. Acetazolamide is a classical and effective sulphonamide hCA inhibitor for systemic therapy of glaucoma. Glaucoma is a chronical and degenerative eye disease, qualified by high intraocular pressure. The main component of aqueous humor is identified as sodium bicarbonate [26, 47] . hCA enzymes responsible for the bicarbonate secretion in the front uvea of the eye. The sulphonamide hCA inhibitors reduce the rate of bicarbonate in the physiological treatment of glaucoma. In this context, the compound 6 which showed the highest inhibitory effect reduces bicarbonate formation inhibiting to carbonic anhydrate reaction. The possible interactions between hCA and compound 6 were shown in the Figure 2 [48] .
In this study, pure A. dracunculus metabolites show inhibitory effect on the hCA I and II isozymes due to functional groups such as -OCH3, -CH3 and -OH existing in their aromatic structure. Our results demonstrate possible new CA inhibitors of interest in addition to the much-used sulfamides/sulfamates/sulfonamides. However, compounds that different chemical-structure showed effective hCA I and II inhibitory activities in the low IC50 values [49] . Our results indicate that these compounds can be used as potent inhibitors.
In conclusion, the extracts of A. dracunculus and its pure metabolites (compounds 1-6) showed enzyme inhibitory effects on the hCA I and II isozymes. These results pointed out the A. dracunculus herb and its pure compounds 1-6 may have beneficial potentials in the treatment of glaucoma. In particular, among the metabolites, 1-(4'-methoxyphenyl)-1,2,3-trihydroxypropane (6) had the highest inhibitory effect on the hCA isozymes and its IC50 values on hCA I and II isozymes were also lower than those of acetazolamide. Our results concluded that compound 6 is a potential natural agent may be use in the glaucoma therapy as well as edema and epilepsy in humans. In addition to these results, studies on toxicity of A. dracunculus should be made in the future.
